In breast cancer, Jeong and colleagues found that PMCA2 knockdown disrupted the interaction between HER2 and HSP90 and promoted the internalization and degradation of HER2, resulting in a reduction in the protein levels of p-EGFR, HER3, and p-HER3, but not EGFR (31). This evidence concerns the gene ATP2B2 and breast carcinoma.